More on NKTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.91 |
|
|||
| Open | $2.88 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.88 | ||||
| Day Low | $2.76 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 559,278 | ||||
- Nkarta to Participate in September Investor Conferences
- Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
- Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses
- Nkarta Inc. (NKTX) PT Lowered to $14 at H.C. Wainwright
- Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c
- Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
- Form 10-Q Nkarta, Inc. For: Jun 30
- Form 8-K Nkarta, Inc. For: Aug 10
- Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
- Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Entities mentioned with NKTX
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Stifel | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
